Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

Overview of attention for article published in European Archives of Oto-Rhino-Laryngology, May 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 6,080 followers.

RT @Arif_Akyildiz_: Our recent study involving patients with head and neck cancer treated with Nivolumab has been published.https://t.co/U7…

RT @Arif_Akyildiz_: Our recent study involving patients with head and neck cancer treated with Nivolumab has been published.https://t.co/U7…

RT @Arif_Akyildiz_: Our recent study involving patients with head and neck cancer treated with Nivolumab has been published.https://t.co/U7…

✨Big thanks to everyone involved, especially @Arif_Akyildiz_, for their hard work!" 👏👏

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.